DK1225890T3 - Rivastigmin til behandling af öjensygdomme - Google Patents
Rivastigmin til behandling af öjensygdommeInfo
- Publication number
- DK1225890T3 DK1225890T3 DK00992430T DK00992430T DK1225890T3 DK 1225890 T3 DK1225890 T3 DK 1225890T3 DK 00992430 T DK00992430 T DK 00992430T DK 00992430 T DK00992430 T DK 00992430T DK 1225890 T3 DK1225890 T3 DK 1225890T3
- Authority
- DK
- Denmark
- Prior art keywords
- rivastigmine
- treatment
- eye diseases
- diseases
- eye
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99120678 | 1999-10-19 | ||
| PCT/EP2000/010234 WO2001028553A1 (en) | 1999-10-19 | 2000-10-17 | Rivastigmine for the treatment of ocular disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1225890T3 true DK1225890T3 (da) | 2005-04-04 |
Family
ID=8239225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00992430T DK1225890T3 (da) | 1999-10-19 | 2000-10-17 | Rivastigmin til behandling af öjensygdomme |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US6534541B1 (ko) |
| EP (1) | EP1225890B1 (ko) |
| JP (1) | JP2003512324A (ko) |
| AR (1) | AR026062A1 (ko) |
| AT (1) | ATE285764T1 (ko) |
| AU (1) | AU766001B2 (ko) |
| CA (1) | CA2384690C (ko) |
| DE (1) | DE60017174T2 (ko) |
| DK (1) | DK1225890T3 (ko) |
| ES (1) | ES2234708T3 (ko) |
| NZ (1) | NZ518164A (ko) |
| PT (1) | PT1225890E (ko) |
| WO (1) | WO2001028553A1 (ko) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1121104E (pt) | 1998-10-01 | 2005-05-31 | Novartis Ag | Novas formulacoes orais de libertacao controlada |
| US8541413B2 (en) * | 2004-10-01 | 2013-09-24 | Ramscor, Inc. | Sustained release eye drop formulations |
| US9993558B2 (en) | 2004-10-01 | 2018-06-12 | Ramscor, Inc. | Sustained release eye drop formulations |
| WO2009022345A1 (en) * | 2007-08-14 | 2009-02-19 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Phenyl carbamates for the treatment of multiple sclerosis |
| US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
| WO2011151359A1 (en) | 2010-06-02 | 2011-12-08 | Noscira, S.A. | Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative |
| CN107417574B (zh) * | 2017-03-21 | 2019-12-03 | 浙江省医学科学院 | 2,4-双取代苯乙酮化合物及其旋光异构体、药学上可接受的盐及应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL74497A (en) * | 1985-03-05 | 1990-02-09 | Proterra Ag | Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives |
| NL195004C (nl) * | 1987-03-04 | 2003-11-04 | Novartis Ag | Fenylcarbamaat bevattend farmaceutisch preparaat. |
| US4900748A (en) | 1988-03-04 | 1990-02-13 | The United States Of America As Represented By The Department Of Health And Human Services | Carbamates related to (-)-physostigmine as cholinergic agents |
| DE69233255T2 (de) | 1991-09-26 | 2004-05-27 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Carbamatanalogen von thiaphysovenin, pharmazeutische zusammensetzungen und verfahren zur hemmung von cholinesterasen |
| DE69233093T2 (de) | 1991-09-26 | 2003-12-18 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Washington | Substituierte phenserine und phenylcarbamate von (-)-eserolin, (-)-n1-noreserolin und (-)-n1-benzylnoresorolin als spezifische acetylcholinesterase-inhibitoren |
| AU1138097A (en) * | 1995-12-22 | 1997-07-17 | Alcon Laboratories, Inc. | Combinations of prostaglandins and miotics for lowering intraocular pressure |
-
2000
- 2000-10-11 US US09/686,025 patent/US6534541B1/en not_active Expired - Fee Related
- 2000-10-17 ES ES00992430T patent/ES2234708T3/es not_active Expired - Lifetime
- 2000-10-17 DE DE60017174T patent/DE60017174T2/de not_active Expired - Lifetime
- 2000-10-17 AT AT00992430T patent/ATE285764T1/de active
- 2000-10-17 AR ARP000105450A patent/AR026062A1/es unknown
- 2000-10-17 NZ NZ518164A patent/NZ518164A/en not_active IP Right Cessation
- 2000-10-17 JP JP2001531383A patent/JP2003512324A/ja active Pending
- 2000-10-17 PT PT00992430T patent/PT1225890E/pt unknown
- 2000-10-17 EP EP00992430A patent/EP1225890B1/en not_active Expired - Lifetime
- 2000-10-17 CA CA2384690A patent/CA2384690C/en not_active Expired - Fee Related
- 2000-10-17 AU AU28349/01A patent/AU766001B2/en not_active Ceased
- 2000-10-17 DK DK00992430T patent/DK1225890T3/da active
- 2000-10-17 WO PCT/EP2000/010234 patent/WO2001028553A1/en active IP Right Grant
-
2003
- 2003-01-23 US US10/349,718 patent/US6835748B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE60017174D1 (de) | 2005-02-03 |
| US20030119832A1 (en) | 2003-06-26 |
| CA2384690A1 (en) | 2001-04-26 |
| EP1225890A1 (en) | 2002-07-31 |
| PT1225890E (pt) | 2005-05-31 |
| US6835748B2 (en) | 2004-12-28 |
| AR026062A1 (es) | 2002-12-26 |
| EP1225890B1 (en) | 2004-12-29 |
| AU2834901A (en) | 2001-04-30 |
| ATE285764T1 (de) | 2005-01-15 |
| WO2001028553A1 (en) | 2001-04-26 |
| CA2384690C (en) | 2010-08-17 |
| AU766001B2 (en) | 2003-10-09 |
| JP2003512324A (ja) | 2003-04-02 |
| US6534541B1 (en) | 2003-03-18 |
| DE60017174T2 (de) | 2005-12-22 |
| ES2234708T3 (es) | 2005-07-01 |
| NZ518164A (en) | 2003-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1093370T3 (da) | Farmaceutisk præparat til behandling af diabetes | |
| DK1147083T3 (da) | Arylpiperazinyl-cyclohexylindolderivater til behandling af depression | |
| DK1144395T3 (da) | 2-amino-benzoxazinon-derivater til behandling af fedme | |
| DK1063990T3 (da) | Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser | |
| DK1196172T3 (da) | (S,S)-reboxetin til behandling af kronisk smerte | |
| DE69903543D1 (de) | Formulierungen zur behandlung von magen-speiseröhren reflux | |
| DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
| FI20000863A (fi) | Uusi hoitomenetelmä | |
| NO20022087D0 (no) | Fremgangsmåte for behandling av diabetes | |
| DK1143977T3 (da) | 2-oxy-benzoxazinonderivater til behandling af obesitas | |
| DK1448205T3 (da) | Kombinationer til behandling af immunoinflammatoriske sygdomme | |
| DK1176964T3 (da) | Brug af ET743 til behandling af cancer | |
| DK1411926T3 (da) | Integrininhibitorer til behandling af öjensygdomme | |
| NO20005179D0 (no) | Medikament behandling | |
| NO20024777L (no) | Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte | |
| NO20024776L (no) | Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte | |
| DK1225890T3 (da) | Rivastigmin til behandling af öjensygdomme | |
| DK1268482T3 (da) | Pyranoindoler til behandling af glaukom | |
| DE60138371D1 (de) | PROSTAGLANDINE zur Behandlung von Lichtstrahlung erzeugten Augenerkrankungen wie Photoretinitis | |
| DK1200447T3 (da) | Oxazinocarbazoler til behandling af CNS-sygdomme | |
| DE60124093D1 (de) | S-methyl-dihydro-ziprasidon zur Behandlung von Augenerkrankungen. | |
| FI4299U1 (fi) | Saunasuodatin | |
| IS6020A (is) | S-nítrósóþíól til meðferðar við blóðrásartruflunum | |
| DK1341766T3 (da) | Imidazolonderivater til behandling af virussygdomme | |
| DK1493442T3 (da) | Reboxetin til behandling af perifer neuropati |